Adela

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.

Xgenera

Xgenera develops a multi-cancer early detection blood test to help clinicians and patients identify multiple cancer types at their earliest stages.

Predicta Biosciences

This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.

Guardant Health

The company develops blood-based tests to detect and monitor cancer for patients, healthcare providers, and biopharmaceutical researchers.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Predicta

Predicta develops blood-based molecular diagnostic tests that provide genomic and immune insights for clinicians to guide treatment for patients with blood cancers.

Avant Genomics

The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.

Hedera

This company develops in-house liquid biopsy tests and genomic analysis software for hospital laboratories to improve oncology care and patient outcomes.